Pharma Reviews: Serum Institute seeks DCGI nod for phase2/3 trials of Oxford's COVID-19 vaccine

The sources told PTI that the Pune-based drug firm submitted its application to ... The firm plans to start phase 2 and 3 human trials in India in August.
Read more: Serum Institute seeks DCGI nod for phase2/3 trials of Oxford's COVID-19 vaccine